Clincosm LogoSign in Get a demo

Congenital Bleeding Disorder

Showing 26 - 50 of 84
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Bleeding Disorder, Haemophilia B Trial in Worldwide (nonacog beta pegol)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia B
  • nonacog beta pegol
  • Los Angeles, California
  • +42 more
Jun 27, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Phoenix, Arizona
  • +56 more
Jun 27, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Concizumab, )

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • Torrance, California
  • +33 more
Jul 20, 2017

Efficacy of NovoSeven® in Glanzmann's Thrombasthenia in Japan

Completed
  • Congenital Bleeding Disorder
  • Glanzmann's Disease
  • eptacog alfa (activated)
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Jul 10, 2017

Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (vatreptacog alfa

Completed
Has Results
  • Congenital Bleeding Disorder
  • +2 more
  • vatreptacog alfa (activated)
  • eptacog alfa (activated)
  • Tucson, Arizona
  • +31 more
Mar 29, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Little Rock, Arkansas
  • +62 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Phoenix, Arizona
  • +37 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Worldwide (eptacog alfa (activated), vatreptacog alfa

Completed
Has Results
  • Congenital Bleeding Disorder
  • +2 more
  • eptacog alfa (activated)
  • vatreptacog alfa (activated)
  • Los Angeles, California
  • +44 more
Jan 23, 2017

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Harrow (NNC172-2021, )

Completed
  • Congenital Bleeding Disorder
  • +3 more
  • Harrow, United Kingdom
    Novo Nordisk Investigational Site
Feb 23, 2017

NovoSeven® Used as On-demand Treatment of Bleeds in Haemophilia

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • eptacog alfa (activated)
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Feb 23, 2017

Congenital Bleeding Disorder, Congenital FXIII Deficiency Trial in Worldwide (catridecacog)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency
  • Phoenix, Arizona
  • +34 more
Jan 10, 2017

Congenital Bleeding Disorder, Congenital FXIII Deficiency Trial in Israel, United Kingdom, United States (catridecacog)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency
  • Boston, Massachusetts
  • +9 more
Jan 10, 2017

NovoSeven® Used in Haemophilia A and B With Inhibitors Under

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • eptacog alfa (activated)
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Feb 22, 2017

NovoSeven® Used in Haemophilia A and B With Inhibitors When

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • eptacog alfa (activated)
  • Tokyo, Japan
    Novo Nordisk Investigational Site
Feb 23, 2017

Living With Haemophilia

Completed
  • Congenital Bleeding Disorder
  • +5 more
  • No treatment given
  • Mississauga, Canada
  • +2 more
Feb 20, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Kuala Lumpur, London (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Kuala Lumpur, Malaysia
  • +2 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Advate®, turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • Berlin, Germany
  • +6 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Berlin, Germany
  • +4 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Iowa City, Iowa
  • +17 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Japan (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Itabashi-ku, Tokyo, Japan
  • +5 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia B Trial in Worldwide (nonacog beta pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia B
  • nonacog beta pegol
  • Cincinnati, Ohio
  • +18 more
Jan 19, 2017

Acquired Bleeding Disorder, Acquired Haemophilia, Congenital Bleeding Disorder Trial in Paris (activated recombinant human

Completed
  • Acquired Bleeding Disorder
  • +7 more
  • activated recombinant human factor VII
  • Paris, France
    Novo Nordisk Investigational Site
Jan 18, 2017

Haemophilia Care and Orthopaedic Status in Developing Countries

Completed
  • Congenital Bleeding Disorder
  • +4 more
  • No treatment given
  • Bangalore, India
  • +3 more
Jan 17, 2017

Pain on Functional Impairment and Quality of Life in Hemophilia

Completed
  • Congenital Bleeding Disorder
  • +4 more
  • No treatment given
  • Plainsboro, New Jersey
    Novo Nordisk Investigational Site
Jan 17, 2017

Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Paris (activated recombinant

Completed
  • Congenital Bleeding Disorder
  • +3 more
  • activated recombinant human factor VII
  • placebo
  • Paris, France
    Novo Nordisk Investigational Site
Jan 12, 2017